Pharmacokinetics of Mitiperstat in Participants With Hepatic Impairment

Clinical trial NCT05751759 · COMPLETED

Trial details

NCT number: NCT05751759
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Hepatic Impairment

Start date: 2023-03-20
Primary completion: 2024-11-21
Enrollment: 31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.